Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
Proteome Science|November 24, 2012
An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromesPhilipp Mahlknecht, Sylvia Stemberger, Fabienne Sprenger, et al.
Journal of Child Neurology|October 1, 2019
Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic NeuritisSoren Jonzzon, Leena Suleiman, Andrew Yousef, et al.
Acta Neuropathologica|April 7, 2011
Pathogenic T cell responses against aquaporin 4Maria Pohl, Marie-Therese Fischer, Simone Mader, et al.
Journal of Neuroimmunology|August 27, 2010
Natalizumab treatment reduces endothelial activity in MS patientsAlban Millonig, Harald Hegen, Franziska Di Pauli, et al.
Acta Neuropathologica|December 20, 2018
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the ratSophie Hillebrand, Kathrin Schanda, Magdalini Nigritinou, et al.
Journal of Neuroimmunology|December 3, 2014
Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomicsThomas Berger, Christian Jacobi, Judith Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiformeMarkus Hutterer, Pjotr Knyazev, Ariane Abate, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2016
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS diseaseAnne-Christine Flach, Tanja Litke, Judith Strauss, et al.
Frontiers in Immunology|December 1, 2022
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorderAngelika Bauer, Dagmar Rudzki, Klaus Berek, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
Proteome Science|November 24, 2012
An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromesPhilipp Mahlknecht, Sylvia Stemberger, Fabienne Sprenger, et al.
Journal of Child Neurology|October 1, 2019
Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic NeuritisSoren Jonzzon, Leena Suleiman, Andrew Yousef, et al.
Acta Neuropathologica|April 7, 2011
Pathogenic T cell responses against aquaporin 4Maria Pohl, Marie-Therese Fischer, Simone Mader, et al.
Journal of Neuroimmunology|August 27, 2010
Natalizumab treatment reduces endothelial activity in MS patientsAlban Millonig, Harald Hegen, Franziska Di Pauli, et al.
Acta Neuropathologica|December 20, 2018
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the ratSophie Hillebrand, Kathrin Schanda, Magdalini Nigritinou, et al.
Journal of Neuroimmunology|December 3, 2014
Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomicsThomas Berger, Christian Jacobi, Judith Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiformeMarkus Hutterer, Pjotr Knyazev, Ariane Abate, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2016
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS diseaseAnne-Christine Flach, Tanja Litke, Judith Strauss, et al.
Frontiers in Immunology|December 1, 2022
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorderAngelika Bauer, Dagmar Rudzki, Klaus Berek, et al.
Pageof 25